|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Albumin liver dialysis as pregnancy-saving procedure in cholestatic liver disease and intractable pruritus显示文摘Progressive familial intrahepatic cholestasis type 3 (PFIC3) is a rare cholestatic liver disease. Such liver disease can get worse by female hormone disorder. Albumin dialysis or Molecular Adsorbent Recirculating System (MARS) has been reported to reverse severe cholestasis-linked pruritus. Here, we report the first use of MARS during a spontaneous pregnancy and its successful outcome in a patient with PFIC3 and intractable pruritus. Albumin dialysis could be considered as a pregnancy-saving procedure in pregnant women with severe cholestasis and refractory pruritus. | Maud Lemoine Aurélie Revaux Claire Francoz Guillaume Ducarme Sabine Brechignac Emmanuel Jacquemin Michèle Uzan Nathalie Ganne-Carrié | 2008 | World Journal of Gastroenterology2008，14，42： | 14 |
| 2 | Portal vein thrombosis, cirrhosis, and liver transplantation显示文摘 | Claire Francoz Dominique Valla Fran?ois Durand | 2012 | Journal of Hepatology2012，，1： | 2 |
| 3 | Portal vein thrombosis, cirrhosis, and liver transplantation显示文摘 | Claire Francoz Dominique Valla Fran?ois Durand | 2012 | Journal of Hepatology2012，，1： | 1 |
| 4 | Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study显示文摘 | Thomas Sersté Claire Francoz Fran?ois Durand Pierre-Emmanuel Rautou Christian Melot Dominique Valla Richard Moreau Didier Lebrec | 2011 | Journal of Hepatology2011，，4： | 1 |
| 5 | Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study显示文摘 | Thomas Sersté Claire Francoz Fran?ois Durand Pierre-Emmanuel Rautou Christian Melot Dominique Valla Richard Moreau Didier Lebrec | 2011 | Journal of Hepatology2011，，4： | 1 |
| 6 | Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria显示文摘 | Christophe Duvoux Fran?oise Roudot–Thoraval Thomas Decaens Fabienne Pessione Hanaa Badran Tullio Piardi Claire Francoz Philippe Compagnon Claire Vanlemmens Jérome Dumortier Sébastien Dharancy Jean Gugenheim Pierre–Henri Bernard René Adam Sylvie Radenne Fa | 2012 | Gastroenterology2012，，4： | 1 |
| 7 | Diabetes mellitus is an independent prognostic factor for major liver‐related outcomes in patients with cirrhosis and chronic hepatitis C显示文摘 | Laure Elkrief Pascale Chouinard Noelle Bendersky David Hajage Béatrice Larroque Gérard Babany Blaise Kutala Claire Francoz Nathalie Boyer Richard Moreau Fran?ois Durand Patrick Marcellin Pierre‐Emmanuel Rautou Dominique Valla | 2014 | Hepatology2014，，3： | 1 |
| 8 | Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites显示文摘 | Thomas Sersté Christian Melot Claire Francoz Fran?ois Durand Pierre‐Emmanuel Rautou Dominique Valla Richard Moreau Didier Lebrec | 2010 | Hepatology2010，，3： | 1 |
| 9 | A prospective analysis of living-liver donation shows a high rate of adverse events显示文摘 | Federica Dondero Oliver Farges Jacques Belghiti Claire Francoz Daniele Sommacale Francois Durand Alain Sauvanet Sylvie Janny Deepak Varma Valerie Vilgrain | 2006 | Journal of Hepato - Biliary - Pancreatic Surgery2006，，2： | 1 |
| 10 | The evaluation of renal function and disease in patients with cirrhosis显示文摘 | Claire Francoz Denis Glotz Richard Moreau Fran?ois Durand | 2010 | Journal of Hepatology2010，，4： | 1 |
| 11 | Liver transplantation for hepatocellular carcinoma: is zero recurrence theoretically possible?显示文摘BACKGROUND: Hepatocellular carcinoma(HCC) recurrence remains a key issue after liver transplantation. This study aimed to determine a subgroup of HCC patients within the Milan criteria who could achieve a theoretical goal of zero recurrence rates after liver transplantation.METHODS: Between 1999 and 2009, 179 patients who received liver transplantation for HCC within the Milan criteria were retrospectively included. Analysis of the factors associated with HCC recurrence was performed to determine the subgroup of patients at the lowest risk of recurrence.RESULTS: Seventy-two percent of the patients received a bridging therapy, including 54 liver resections. Eleven(6.1%) patients recurred within a delay of 19±22 months and ultimately died. Factors associated with recurrence were serum alpha-fetoprotein level >400 ng/m L, satellite nodules, poor differentiation, microvascular invasion and cholangiocarcinoma component. Recurrence rates decreased from 6.1% to 3.1% in patients without any of these factors.CONCLUSIONS: Among HCC patients within the Milan criteria, selecting patients with factors based on histology would allow tending towards zero recurrence, and prior histological assessment by liver biopsy or resection may be essential to rule out poorly differentiated tumors, microvascular invasion,and cholangiocarcinoma component. | Sabine Irtan Louise Barbier Claire Francoz Federica Dondéro Francois Durand Jacques Belghiti | 2016 | Hepatobiliary & Pancreatic Diseases International2016，15，2： | 1 |
| 12 | Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites显示文摘 | Thomas Sersté Thierry Gustot Pierre-Emmanuel Rautou Claire Francoz Hassane Njimi Francois Durand Dominique Valla Didier Lebrec Richard Moreau | 2012 | Journal of Hepatology2012，，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员